SYDNEY-In an attempt to cure diabetes, an Australian researcher has developed a drug that may fight fat.
Frank NG of Melbourne's Monash University reports the drug has completed two human trials and is fairing well. No serious side effects have been reported. The drug, called Advanced Obesity Drug 9604, is created from an aspect of human growth hormones that research showed reduces body fat.
Created with help from Melbourne-based Metabolic Pharmaceuticals Ltd., officials reported 22 trial participants received the drug intravenously and found it to be safe. They lost an average of 1.1 pounds during the 4-week trial.
The research in body-weight reducing drugs is increasing after officials from the World Health Organization (WHO) reported 300 million people are estimated to have diabetes by 2025. Non-communicable diseases, such as diabetes Type 2, are set to become a pandemic within this century.
Information from www.reuters.com
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.